CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- 4 Derivatives Options or other derivatives
- SC TO-T/A Deal Tender Offer Statement
- 4 Open-market buy EVP,Chief Med.Offr.,Drug Dev. bought 4,250 shares at $47.58 ($202,215)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- SC TO-T/A Deal Tender Offer Statement
- SC TO-T/A Deal Tender Offer Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEFA14A Proxy Proxy Materials
- SC TO-T Deal Tender Offer Statement
- 4 Shares withheld for taxes EVP, Glob. Prod. Dev. & Supply gave up 1,692 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 8 of 178 · 3,543 filings